Aug 25 (Reuters) – Ultragenyx Pharmaceutical Inc.: * ULTRAGENYX REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)